Results 31 to 40 of about 11,188,116 (297)

The MANAGE trial [PDF]

The Lancet, 2019
Wilton A, van Klei, Jan M, Dieleman, W Scott, Beattie   +2 more
  +8 more sources

Women and children’s real-world economic and drug indicators from 2015 to 2019

Journal of Market Access & Health Policy, 2023
Objectives: To obtain real-world data on rational drug use, pharmacoeconomic regarding women’s and children’s health and the benefits of Hainan free trade port (HFTP) health policies, we retrospectively investigated drug indicators, prescribing trend ...
Jun Zou, Che Zhang, Guohua Jia, Wei Lu
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Public and patient involvement (PPI) in the design, execution and dissemination of a trial: the BISTRO trial

Health Technology Assessment
Background For people receiving haemodialysis, a balance has to be struck between removing sufficient but not too much fluid during a treatment session and maintaining any remaining kidney function they might have.
David Coyle, Paula Ormandy, Nancy Fernandes da Silva, Simon Davies   +3 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

GOLD-concordant inhaled maintenance therapy at hospital discharge after hospitalisation for severe COPD exacerbation: a multicentre retrospective observational studyResearch in context

The Lancet Regional Health. Europe
Summary: Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of global morbidity, with frequent exacerbations resulting in hospitalizations, increased healthcare burdens, and mortality.
Catharina Peukert, Stefan Kwast, Sven Hohenstein, Victoria Pradler, Sebastian König, Torsten Bauer, Thomas Armbrust, Nikolaus Büchner, Kristina Probst, Anika Laing, Dörte Anderson, Kathrin Kahnert, Andreas Bollmann, Ralf Kuhlen, Michael Gediga, Kurt Rasche   +15 more
doaj   +1 more source

N management trial

, 2016
N management trial in ...
liu, hongyan
core   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Friction underwear for ease of pulling down in elderly patients with overactive bladder: A prospective randomized control trial [PDF]

Investigative and Clinical Urology, 2019
Purpose: Friction underwear was developed by adding small silicon dots in front of the underwear to decrease the time for pulling down underwear in elderly patients with urge incontinence.
Jae Hyung You, Yu Seob Shin, Myoung-Hwan Ko, Eun Jin Jeon, Heecheon You, Jong Kwan Park   +5 more
doaj   +1 more source